Latest News
Janux Therapeutics, Inc.
- H.C. Wainwright reiterates Janux stock rating, $45 target By Investing.com
- Janux Therapeutics (NasdaqGM:JANX) Stock Forecast & Analyst Predictions
- Is Janux Therapeutics (JANX) Pricey After Its Recent Swings?
- Janux Therapeutics (JANX) Slips 0.18% to $16.93, Holding Mid-Range Between Key Levels - Growth Stock Picks
- Is First Patient Dosed Altering The Investment Case For Janux Therapeutics (JANX)?
- Janux Therapeutics (JANX) Slips 2.28% to $16.30, Sitting Mid-Range Between Key Levels - Stop Run
Headlines from the last 30 days, linking to the original publishers. See all market news →